Skip to main content

Peer Review reports

From: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals

Original Submission
9 Aug 2017 Submitted Original manuscript
12 Feb 2018 Reviewed Reviewer Report - James Raftery
19 Feb 2018 Reviewed Reviewer Report - Mark Sculpher
30 Mar 2018 Author responded Author comments - Liz Morrell
Resubmission - Version 2
30 Mar 2018 Submitted Manuscript version 2
10 Apr 2018 Reviewed Reviewer Report - James Raftery
19 Apr 2018 Reviewed Reviewer Report - Mark Sculpher
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Apr 2018 Editorially accepted
31 May 2018 Article published 10.1186/s12913-018-3162-2

You can find further information about peer review here.

Back to article page